Tailor-made, innovative and with greater collaboration between public and private. Italians see it this way healthcare of the futureaccording to the photograph taken from a report made by Censis in collaboration with Janssen Italia on healthcare in our country, presented on the occasion of the first edition of ‘The Italian Health Day‘, which was held today in Rome. The research was conducted within the project ‘The construction sites for the health of the future‘, started in 2021 by Censis And Janssen Italy. Italians seem to have very clear ideas on the characteristics of post-Covid in this sector and on the protagonists who will animate it: citizens who are increasingly informed, responsible and involved; the doctor responsible for health; innovators (researchers and companies). An ecosystem increasingly oriented to the personalization of care in the triple challenge of managing acute, chronic disease and new emergencieswithout forgetting economic sustainability.
As far as innovation is concerned, almost all people trust scientific researchers (90.9%) and still more than 9 out of 10 believe that public spending on health represents an investment and not a cost (93.7%). Both for scientific experimentation and to ensure that treatments reach patients quickly, cooperation between states and pharmaceutical companies (90%) is essential, as they enjoy the trust of 2 out of 3 Italians (66.4%). Innovators, including businesses, are no longer perceived as an external component of healthcare, but as decisive actors who make it possible to optimize the impact on patients’ health and quality of life. The key word of the Censis report, which expresses shared ideas and expectations at both a social and institutional level, is for 2022 ‘Renewal‘: a neologism composed of research, innovation, action and renewal.
“The Italians, grateful to health care for what they did in an emergency – he said during the presentation Massimiliano Valerii, general manager of Censis – now they look at it projected towards the future. Personalization of care, higher outcomes, better quality of life and economic sustainability are the variables of a difficult equation which, if the role of innovators, from researchers to drug companies, much appreciated by citizens, is properly valued, will undoubtedly be resolved. . Not surprisingly, in the majority Italians are convinced that in the next few years, also thanks to the lessons of this two-year period, the National Health Service is destined to improve. The many future challenges, starting with need to respond to chronicity, acute situations and emergenciescertainly require more resources, more staff, more beds and more services, but for everything to be sustainable in the long term, it is crucial to give a strong boost to innovation and research, from medicines to services to the intelligent use of data. so as to maximize the health value “.
“We are delighted to be able to continue the debate on the health of the future together with Censis,” he said Massimo Scaccabarozzi, president of Janssen Italia and Head of External Affairs Johnson & Johnson Italia. “The report presented today – he added – clearly shows what Italians expect from post-Covid healthcare and we can only agree with what they have expressed, starting with the request for a greater public-private collaboration to bring innovation to patients ever faster. We are also pleased to note that Italians place a high degree of trust in pharmaceutical companies and that their role is recognized in the field of innovation, both in emergencies and in ordinary situations. In fact, clinical research represents the lifeblood of our company, just think that they are well 14 new molecules Janssen is working onespecially in the oncological and immunological fields, so that they are available to patients “.
According to the Italians, the healthcare of the future will have to be increasingly ‘patient-centric’ and tailor-made: 94.3% hoped for greater personalization of care, with 92.9% expecting that the treatment pathways, from the home to the community to the hospitals, would be tailored to the personal needs of the patient.
“Putting the patient at the center – he said Anna Lisa Mandorino, general secretary of Cittadinanzattiva – means reversing the perspective and thinking of health services that reach citizens, are close and widespread in the area, and make use of digitization as a tool to respond quickly and personalized to their needs. At the same time, above all for the paths of prevention and management of chronic diseases, there must be a very close network of links between professionalsstarting with general practitioners, pediatricians of free choice and operators present in the new community homes: in this way we can overcome the challenge of truly strengthening local assistance, as envisaged by the NRP “.
The report shows that 9 out of 10 Italians trust doctors (92.1%) and for as many their figure will have to be at the center of the healthcare of the future (93.9%). The percentage of citizens who trust the health service of their region is also very high (73.2%). A capital that is projected forward: 61% of Italians are convinced that in the coming years, thanks to the lessons learned from the pandemic, our health will improve. A healthcare system that must be ready not only for possible new emergencies, but also for the socio-demographic forecasts of our country: from the evolution of family forms with the demographic decline and the increase in single-member families, to the lengthening of life expectancy with the consequent aging of the population and the multiplication of disabling and chronic diseases, which generate high social, health and assistance needs.
The presentation of the report was also attended by Alice Borghini, director of territorial health models organization of the National Agency for Regional Health Services (Agenas), and Daiana Taddeo, national research area of the Italian Society of General Medicine and Primary Care (Simg).
